Memo3D ReChord

Device LivaNova USA, Inc.
Total Payments
$38,207
Transactions
5
Doctors
3
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2020 $38,000 2 0
2019 $135.07 1 1
2018 $71.57 2 2

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $38,000 2 99.5%
Food and Beverage $206.64 3 0.5%

Payments by Type

Research
$38,000
2 transactions
General
$206.64
3 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Evaluation of Mitral Valve Anterior Leaflet Repair Using the Memo 3D ReChord Annuloplasty Ring LivaNova USA, Inc. $38,000 0

Top Doctors Receiving Payments for Memo3D ReChord

Doctor Specialty Location Total Records
Unknown Ann Arbor, MI $38,000 2
, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Minneapolis, MN $135.07 1
, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Detroit, MI $35.79 1
, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Detriot, MI $35.78 1

About Memo3D ReChord

Memo3D ReChord is a device associated with $38,207 in payments to 3 healthcare providers, recorded across 5 transactions in the CMS Open Payments database. The primary manufacturer is LivaNova USA, Inc..

Payment data is available from 2018 to 2020. In 2020, $38,000 was paid across 2 transactions to 0 doctors.

The most common payment nature for Memo3D ReChord is "Unspecified" ($38,000, 99.5% of total).

Memo3D ReChord is associated with 1 research study, including "Evaluation of Mitral Valve Anterior Leaflet Repair Using the Memo 3D ReChord Annuloplasty Ring" ($38,000).